Summary
Intuitive Surgical Inc. demonstrated significant growth in 2005, with sales increasing by 64% to $227.3 million, driven by the expanding adoption of its da Vinci Surgical System. The company saw strong performance across multiple surgical specialties, particularly in urology, and noted a substantial increase in recurring revenue from instruments, accessories, and service, which constituted 45% of total sales. Key strategic achievements included expanding FDA clearances for broader urologic and gynecologic procedures, and the successful market penetration in the radical prostatectomy segment, capturing approximately 20% of the U.S. market by year-end. Financially, Intuitive Surgical reported a substantial increase in operating income to $68.8 million, a 225% jump from the previous year, and improved gross profit margins to 68%. The company also strengthened its financial position with a significant increase in cash, cash equivalents, and investments, ending the year with over $200 million. Significant investments were made in expanding facilities to support future growth, including the acquisition of a new campus. The company launched the da Vinci S Surgical System in early 2006, signaling continued innovation and a commitment to enhancing its product line.
Key Highlights
- 1Sales grew by 64% to $227.3 million in 2005, demonstrating strong market adoption of the da Vinci Surgical System.
- 2Recurring revenue (instruments, accessories, service, training) increased by 71% to $102.7 million, representing 45% of total sales, indicating a growing services-based revenue stream.
- 3The company captured approximately 20% market share in U.S. radical prostatectomy procedures by year-end 2005, a significant increase from previous years.
- 4Operating income more than tripled, growing 225% to $68.8 million, highlighting improved operational leverage and profitability.
- 5Gross profit margin improved significantly to 68% from 63% in 2004, driven by increased sales volume and operational efficiencies.
- 6The company received expanded FDA clearances for urologic and gynecologic surgical procedures in 2005.
- 7Intuitive Surgical launched the new da Vinci S Surgical System in January 2006, indicating ongoing product development and market expansion efforts.